Vimarsana.com

Latest Breaking News On - Kathleena rickard - Page 1 : vimarsana.com

Verona Pharma (NASDAQ:VRNA) Shares Up 8.4%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price rose 8.4% during mid-day trading on Wednesday . The stock traded as high as $14.56 and last traded at $14.49. Approximately 546,673 shares were traded during trading, a decline of 3% from the average daily volume of 565,092 shares. The stock had previously closed at […]

Verona-pharma
Kathleena-rickard
Piper-sandler
Hood-river-capital-management
Bellevue-group
Virtu-financial
Janus-henderson-group
Ikarian-capital
Nasdaq
Securities-exchange-commission
Get-free-report
Exchange-commission

Bellevue Group AG Has $16.70 Million Holdings in Verona Pharma plc (NASDAQ:VRNA)

Bellevue Group AG decreased its position in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 839,996 shares of the company’s stock after selling 16,362 shares during the period. Bellevue Group AG owned about 1.05% of Verona Pharma […]

United-states
American
Verona-pharma
Piper-sandler
Kathleena-rickard
American-century-companies-inc
Hermes-inc
Clearbridge-investments
Eventide-asset-management
Nasdaq
Bellevue-group
First-turn-management

Verona Pharma (NASDAQ:VRNA) Trading Up 4.5%

Verona Pharma (NASDAQ:VRNA) Trading Up 4.5%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Kathleena-rickard
Verona-pharma
Rathbones-group
Jump-financial
Cape-investment-advisory-inc
Nasdaq
Verona-pharma-company-profile
Tower-research-capital
Get-free-report
Investment-advisory
Research-capital

Verona Pharma (NASDAQ:VRNA) Sets New 12-Month Low at $11.79

Verona Pharma (NASDAQ:VRNA) Sets New 12-Month Low at $11.79
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kathleena-rickard
Verona-pharma
Piper-sandler
Hermes-inc
Eventide-asset-management
Nasdaq
Moody-aldrich-partners
Campbell-co-investment-adviser
Rathbones-group
Get-free-report
Aldrich-partners
Verona-pharma-daily

Verona Pharma (NASDAQ:VRNA) Sets New 12-Month Low at $11.79

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $11.79 and last traded at $11.85, with a volume of 760873 shares trading hands. The stock had previously closed at $12.43. Analyst Ratings Changes VRNA has been the topic […]

United-states
Wellington
New-zealand-general
New-zealand
American
Kathleena-rickard
Verona-pharma
Piper-sandler
Securities-exchange-commission
Clearbridge-investments
Wellington-management-group
American-century-companies-inc

HC Wainwright Cuts Verona Pharma (NASDAQ:VRNA) Price Target to $30.00

Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective cut by HC Wainwright from $33.00 to $30.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s FY2024 earnings at ($1.36) EPS, Q1 2025 earnings at ($0.24) […]

Piper-sandler
Verona-pharma
Kathleena-rickard
Sei-investments-co
Securities-exchange-commission
A-davidson
Campbell-co-investment-adviser
Capital-management
Cape-investment-advisory-inc
Free-report
Pharma-stock-down
Get-free-report

First Turn Management LLC Invests $23.98 Million in Verona Pharma plc (NASDAQ:VRNA)

First Turn Management LLC Invests $23.98 Million in Verona Pharma plc (NASDAQ:VRNA)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
United-states
American
Piper-sandler
Verona-pharma
Kathleena-rickard
Nasdaq
American-century-companies-inc
Exchange-commission
Securities-exchange-commission

Verona Pharma (NASDAQ:VRNA) Given "Buy" Rating at HC Wainwright

Verona Pharma (NASDAQ:VRNA) Given "Buy" Rating at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
Martin-edwards
Kathleena-rickard
Verona-pharma
Wellington-management-group
Securities-exchange-commission
Jennison-associates
Hermes-inc
Eventide-asset-management
Free-report

Verona Pharma (NASDAQ:VRNA) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $32.00 price objective on the stock. Separately, Wedbush reiterated an outperform rating and issued a $33.00 target price on shares of Verona Pharma in a research report on […]

Kathleena-rickard
Martin-edwards
Verona-pharma
Schonfeld-strategic-advisors
Hermes-inc
Citigroup-inc
Securities-exchange-commission
Eventide-asset-management
Free-report
Get-free-report
Exchange-commission
Director-martin-edwards

Verona Pharma (NASDAQ:VRNA) Stock Rating Reaffirmed by HC Wainwright

Verona Pharma (NASDAQ:VRNA) Stock Rating Reaffirmed by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Verona-pharma
Martin-edwards
Kathleena-rickard
Envestnet-asset-management-inc
Renaissance-technologies
Verona-pharma-company-profile
Goldman-sachs-group-inc
Cubist-systematic-strategies
Securities-exchange-commission
Citigroup-inc
Get-free-report
Exchange-commission

vimarsana © 2020. All Rights Reserved.